TEESE eS SS, ESS Seria Satacbuters, "Elec be |e |e |e eae Tetbutaine, 2, Seo ii) Sima" reneon Bat Metaproterenol, —” femmatcaik tonsa ‘ole LABA-Salmetero, Formoterol ane Theophylline Methyxanthnes 1. ib AM? L ga uineonetiereyor Said eeniecral 1. Narow bape nl Se =. ae = — a ee ee fe ea ees a 1. Radiata snus of halon MananncaerpyforTisste dong rage tnflammatory Stommirseay sch We creme ‘edwemptecomcyans|—Soegy men hae, Systemic. Agent Siero Sinners" Satin and mes prednisone,methylpre ihren ett Anisone ae eeopuonn catracs Inhalation= aan sna Beclomethasone, seein desion Flunisolide Fluticasone Sane sudesonide: Fite emma aa 1. Deetantealatnot hain — apa aayfor 1. Ue port cin | oceans eoghing fea ‘ete hme reveling tendon 2 Und port cos Agent naa uesenene feakoreneecepors Brtekinendoopn iwan 3 Rain Montelukast Inhibitor 2 Thecies weenie eee Prortocokar " Zileuton or ee Oe eee ce a ee inhibitor ‘ethos 2. Amigesnouces GeneMechanisms of | Therapeutic | Route of Coa a Kees) ena is fee |e ‘locks histamine Allergic rhinitis, Oral and inravenous Marked sedation Histamine HT M1 receptors Urticaria and for agitation cue receotor adjunctive to muscarinic antagonist- 1 therapy in receptor generation anapnyiacae blockade CTL Blocks histamine Allergic rhinitis, Oral Slight sedation Histamine HT CEN Hi receptors Common oragitation cue recentor ingredient in OTC to muscarinic _antagonist- 1st medication: receptor generation a Blocks histamine Allergic rhinitis, Oral Histamine HY cose) M1 receptors leiopathic chronic receptor cara antagonist- 2nd generation Toraikine Blocks hstemine Allergic rhinitis, Oral Neuses, fatigue, Histamine Cr HY receptors allergic reactions headache recestor 1 blood, antagonist- 2nd ancadjunctve therapy in anapnyacic ‘Catnzine Blocks histamine Allergic rhinitis, ral ‘Sedation, fatigue Histamine HY Coes) M1 receptors and isiopathic chronic and dry mouth receptor Dlecks histamine utiaria antagonist- 2nd release generation Daren Blocks nstemine Chronic uticara Oral Disorientation, Histamine Coe HY receptors not responding 0 confusion in receptor other HY noncdepressed antagonist 2nd antagonists patents